Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
出版年份 2017 全文链接
标题
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 10, Pages 2344-2350
出版商
Wiley
发表日期
2017-02-16
DOI
10.1002/ijc.30650
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
- (2016) Naoto Hadano et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection ofKRASMutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer
- (2016) Nora Brychta et al. CLINICAL CHEMISTRY
- Opportunities and Challenges for Pancreatic Circulating Tumor Cells
- (2016) Sunitha Nagrath et al. GASTROENTEROLOGY
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Detection ofK-rasgene mutation by liquid biopsy in patients with pancreatic cancer
- (2015) Hideaki Kinugasa et al. CANCER
- Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility
- (2015) M. Ignatiadis et al. CLINICAL CANCER RESEARCH
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- Molecular landscape of pancreatic cancer: implications for current clinical trials
- (2015) Gregory M. Heestand et al. Oncotarget
- Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
- (2014) L. De Mattos-Arruda et al. ANNALS OF ONCOLOGY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies
- (2013) Lorenzo Fuccio et al. GASTROINTESTINAL ENDOSCOPY
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing
- (2012) C. A. Iacobuzio-Donahue et al. CLINICAL CANCER RESEARCH
- Combinational therapy: New hope for pancreatic cancer?
- (2011) Si Shi et al. CANCER LETTERS
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
- (2011) Hedy L Kindler et al. LANCET ONCOLOGY
- ATM Mutations in Patients with Hereditary Pancreatic Cancer
- (2011) Nicholas J. Roberts et al. Cancer Discovery
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions
- (2009) Daniele Marrelli et al. AMERICAN JOURNAL OF SURGERY
- Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer
- (2009) Marc D. Tischkowitz et al. GASTROENTEROLOGY
- Adjuvant therapy for pancreatic cancer
- (2007) Dan S. Zuckerman et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started